(Q36053459)

English

Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

author name string

L Thorsson

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

O Borgâ

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

S Edsbäcker

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

1 June 1999

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

47

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

619-624

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014261

2 October 2017

The clinical efficacy of budesonide in hay fever treatment is dependent on topical nasal application

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014261

2 October 2017

Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014261

27 July 2018

Hypertension and pathologic cardiovascular remodeling: a potential therapeutic role for T-type calcium antagonists

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00956.X

21 January 2018

Nasal delivery systems and their effect on deposition and absorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/10383539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of (22R,S)budesonide in human plasma by automated liquid chromatography/thermospray mass spectrometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/10383539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deposition pattern from a nasal pump spray

1 reference

https://pubmed.ncbi.nlm.nih.gov/10383539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The nasal distribution of metered dose inhalers

1 reference

https://pubmed.ncbi.nlm.nih.gov/10383539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/10383539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deposition pattern of nasal sprays in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/10383539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nasal mucociliary clearance in perennial rhinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10383539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anatomy, physiology and function of the nasal cavities in health and disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10383539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Budesonide aqueous nasal spray and pressurized metered dose inhaler in the treatment of adult patients with seasonal allergic rhinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10383539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative assessment of safety and efficacy of inhaled corticosteroids: report of a committee of the Canadian Thoracic Society

1 reference

https://pubmed.ncbi.nlm.nih.gov/10383539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nasal distribution of budesonide inhaled via a powder inhaler

1 reference

https://pubmed.ncbi.nlm.nih.gov/10383539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

1 reference

https://pubmed.ncbi.nlm.nih.gov/10383539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single blind clinical comparison between 2 preparations of budesonide in the treatment of seasonal allergic rhinitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10383539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nasal bioavailability and systemic effects of the glucocorticoid budesonide in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/10383539

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1046/J.1365-2125.1999.00956.X

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36053459&oldid=1964025083"